Acadia Healthcare Co (Acadia Healthcare Co) Risk Assessment

View and export this data going back to 2011. Start your Free Trial

What is Acadia Healthcare Co Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Acadia Healthcare Co is: Moderate Risk: Sensitive, better choose undervalued stock.

Competitive Comparison of Acadia Healthcare Co's Risk Assessment

For the Medical Care Facilities subindustry, Acadia Healthcare Co's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Acadia Healthcare Co's Risk Assessment Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Acadia Healthcare Co's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Acadia Healthcare Co's Risk Assessment falls into.

Acadia Healthcare Co (NAS:ACHC) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Acadia Healthcare Co Risk Assessment Related Terms

Thank you for viewing the detailed overview of Acadia Healthcare Co's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Acadia Healthcare Co (Acadia Healthcare Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Acadia Healthcare Co Inc (NAS:ACHC) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

7RA:Germany

Address

6100 Tower Circle, Suite 1000, Franklin, TN, USA, 37067

Website

https://www.acadiahealthcare.com

Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities in the United States, United Kingdom, and Puerto Rico. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The U.S. facilities receive the largest proportion of payments from Medicaid, with the second-largest proportion from commercial payors. In the United Kingdom, the majority of Acadia's revenue comes from its healthcare facilities, and virtually all of the payment received is from the National Health Service.

Executives

Debra K Osteen	director, officer: Chief Executive Officer	367 SOUTH GULPH ROAD, KING PRUSSIA PA 19406
John S. Hollinsworth	officer: EVP of Operations	6100 TOWER CIRCLE, SUITE 1000, FRANKLIN TN 37067
Patrice A Harris	director	514 MARKET ST., PARKERSBURG WV 26101
Brian Farley	officer: EVP , GC and Secretary	222 MERCHANDISE MART PLAZA, SUITE 2024, CHICAGO IL 60654
Heather Brianne Dixon	officer: Chief Financial Officer	AETNA INC., 151 FARMINGTON AVENUE, HARTFORD CT 06156
William Grieco	director	830 CRESCENT CENTRE DRIVE, SUITE 610, FRANKLIN TN 37067
William M Petrie	director	310 25TH AVENUE NORTH, SUITE 309, NASHVILLE TN 37203
Ralph David Kelly	director	4005 WOOD LAKE DRIVE, PLANO TX 75093
Christopher H. Hunter	director, officer: Chief Executive Officer	500 W MAIN STREET, LOUISVILLE KY 40202
Reeve B Waud	director, 10 percent owner	300 N LASALLE ST, SUITE 4900, CHICAGO IL 60654
David M. Duckworth	officer: Chief Financial Officer	830 CRESCENT CENTRE DRIVE, SUITE 610, FRANKLIN TN 37067
Christopher L Howard	10 percent owner, officer: EVP, GC and Secretary	830 CRESCENT CENTRE DRIVE, SUITE 610, FRANKLIN TN 37067
Michael Fucci	director	6100 TOWER CIR #1000, FRANKLIN TN 37067
Jason Bernhard	director	6100 TOWER CIRCLE, SUITE 1000, FRANKLIN TN 37067
Laurence L. Harrod	officer: EVP of Finance	6100 TOWER CIRCLE, SUITE 1000, FRANKLIN TN 37067